Hypothesis: An angiotensin converting enzyme genotype, present in one in three caucasians, IS associated with an increased mortality rate

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 1, 1996, Pages 1-10

  Morris, Brian J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Angiotensin converting enzyme; Coronary artery disease; Death; Dipeptidyl carboxypeptidase 1; Molecular genetics; Mortality; Myocardial infarction; Polymerase chain reaction; Ventricular hypertrophy

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; CARDIOVASCULAR DISEASE; GENETICS; GENOTYPE; HUMAN; MIDDLE AGED; REVIEW; RISK FACTOR;

ADULT; AGED; CARDIOVASCULAR DISEASES; GENOTYPE; HUMANS; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; RISK FACTORS;

EID: 0029685836     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb03054.x     Document Type: Review

References (81)

1. National Heart Foundation of Australia. Heart Facts 1992. National Heart Foundation, Sydney. 1992.
2. Hubert C, Houot A-M, Corvol P, Soubrier F. Structure of the angiotensin I-converting enzyme gene. Two alternative promoters correspond to evolutionary steps of a duplicate gene. J. Biol. Chem. 1991; 266: 15377-83.
3. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 1990; 86: 1343-6.
4. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1; dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 1992; 20: 1433.
5. Mattei MG, Hubert C, Alhenc-Gelas F, Roeckel N, Corvol P, Soubrier F. Angiotensin converting enzyme gene is on chromosome 17. Cytogenet. Cell Genet. 1989; 51: 1041.
6. Barley J, Blackwood A, Carter ND et al. Angiotensin converting enzyme insertion/deletion polymorphism: Association with ethnic origin. J. Hypertens. 1994; 12: 955-7.
7. Rutledge DR, Browe CS, Ross EA. Frequencies of the angiotensinogen and angiotensin I converting enzyme (ACE) gene polymorphisms in African Americans. Biochem. Mol. Biol. Int. 1994; 34: 1271-5.
8. Rutledge DR, Kubilis P, Browe CS, Ross EA. Polymorphism of the angiotensin I converting enzyme gene in essential hypertensive patients. Biochem Mol. Biol. Int. 1993; 35: 661-8.
9. Kojima S, Inenaga T, Matsuoka H et al. The association between salt sensitivity of blood pressure and some polymorphic factors. J. Hypertens. 1994; 12: 797-801.
10. Nakai K, Itoh C, Miura Y et al. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1994; 90: 2199-202.
11. Ohishi M, Fujii K, Minamino T et al. A potent genetic risk factor for restenosis. Nature Genetics 1994; 5: 324-5.
12. Zhao Y, Higashimori K, Higaki J et al. Significance of the deletion polymorphism of the angiotensin converting enzyme gene as a risk factor for myocardial infarction in Japanese. Hypertens. Res. 1994; 17: 55-7.
13. Lee EJD. Population genetics of the angiotensin-converting enzyme in Chinese. Br. J. Clin. Pharmacol. 1994; 37: 212-14.
14. Tiret L, Rigat B, Visvikis S et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin-I-converting enzyme (ACE) gene controls plasma ACE levels. Am. J. Hum. Genet. 1992; 51: 197-205.
15. Harrap SB, Davidson HR, Connor JM et al. The angiotensin I-converting enzyme gene and predisposition to high blood pressure. Hypertension 1993; 21: 455-60.
16. Higashimori K, Zhao Y, Higaki J et al. Association analysis of a polymorphism of the angiotensin converting enzyme gene with essential hypertension in the Japanese population. Biochem. Biophys. Res. Commun. 1993; 191: 399-404.
17. Morris BJ, Monaghan JC, Perich R, Stokes GS, Jackson B, Schrader AP. Genotypic influence on plasma dipeptidyl carboxypeptidase-1 activity in hypertensives. Clin. Exp. Pharmacol. Physiol. 1994; 21: 343-6.
18. Johnson GS, Shibuya H, Ganjam K et al. An A/G polymorphism near the 3′ splice site in the last intron of the human angiotensin converting enzyme gene may promote alternative splicing. Circulation 1993; 88 (Suppl. 1): 233 (abstract).
19. Doria A, Warram JH, Rich SS, Krolewski AS. Angiotensin I-converting enzyme (ACE): Estimation of DNA haplotypes in unrelated individuals using denaturing gradient gel blots. Hum. Genet. 1994; 94: 117-23.
20. Morris BJ. No difference in substrate affinity of plasma dipeptidyl carboxypeptidase-1 encoded by the I and D allelic forms of its gene. Pharmacogenet. 1994; 4: 223-4.
21. Zee RYL, Lou Y-K, Griffiths LR, Morris BJ. Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. Biochem. Biophys. Res. Commun. 1992; 184: 9-15.
22. Morris BJ, Zee RYL, Ying L-H, Griffiths LR. Independent, marked associations of alleles of the insulin receptor and dipeptidyl carboxypeptidase-1 genes with essential hypertension. Clin. Sci. 1993; 85: 189-95.
23. Morris BJ, Zee RYL, Schrader AP. Different frequencies of angiotensin-converting enzyme genotypes in older hypertensive individuals. J. Clin. Invest. 1994; 94: 1085-9.
24. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel J-M. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nature Genetics 1992; 1: 72-5.
25. Jeunemaitre X, Soubrier, F, Kotelevtsev YV et al. Molecular basis of human hypertension: Role of angiotensinogen. Cell 1992; 71: 169-80.
26. Schmidt S, van Hooft IMS, Grobbee DE, Ganten D, Ritz E. Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring Study. J. Hypertens. 1993; 11: 345-8.
27. Morris BJ, Zee RYL. Similarity of blood pressure for each genotype of the insertion/deletion polymorphism of the dipeptidyl carboxypeptidase-1 gene in different age groups of patients with severe, familial essential hypertension. Clin. Exp. Pharmacol. Physiol. 1994; 21: 919-24.
28. Berge KE, Berg K. No effect of insertion/deletion polymorphism at the ACE locus on normal blood pressure level or variability. Clin. Genet. 1994; 45: 169-74.
29. Duru K, Farrow S, Wang J-M, Lockette W, Kurtz T. Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African-Americans with hypertension. Am. J. Hyperten. 1994; 7: 759-62.
30. Cambien F, Costerousse O, Tiret L et al. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 1994; 90: 669-76.
31. Doria A, Warram JH, Krolewski AS. Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I-converting enzyme gene. Diabetes 1994; 43: 690-5.
32. Kupari M, Perola M, Koskinen P, Virolainen J, Karhunen PJ. Left ventricular size, mass, and function in relation to angiotensin-converting enzyme gene polymorphism in humans. Am. J. Physiol. 1994; 267: H1107-11.
33. Cambien F, Poirer O, Lecerf L et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-4.
34. Tiret L, Kee F, Poirier O et al. Deletion polymorphism in the angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 1993; 341: 991-2.
35. Evans AE, Poirer O, Kee F et al. Polymorphisms of the angiotensin-converting enzyme gene in subjects who die from coronary heart disease. Q. J. Med. 1994; 87: 211-14.
36. Berge KE, Bøhn M, Berg K. DNA polymorphism at the locus for angiotensin I-converting enzyme in Norwegian patients with myocardial infarction. Clin. Genet. 1994; 46: 102-4.
37. Bøhn M, Berge, KE, Bakken A, Erikssen J, Berg K. Insertion/ deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction. Clin. Genet. 1993; 44: 292-7.
38. Bøhn M, Berge KE, Bakken A, Erikssen J, Berg K. Insertion/ deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and parental history of myocardial infarction. Clin. Genet. 1993; 44: 298-301.
39. Miettinen H, Korpela K, Hämäläinen L, Kontula K. Polymorphisms of the apolipoprotein and angiotensin converting enzyme genes in young North Karelian patients with coronary heart disease. Hum. Genet. 1994; 94: 189-92.
40. Mattu RK, Needham EWA, Galton DJ, Frangos E, Clark AJL, Caulfield M. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study. Circulation 1995; 91: 270-4.
41. Badenhop RF, Wang XL, Wilcken DEL. Angiotensin-converting enzyme genotype in children and coronary events in their grandparents. Circulation 1995; 91: 1655-8.
42. Tiret L, Bonnardeaux A, Poirer O et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphism on risk of myocardial infarction. Lancet 1994; 344: 910-13.
43. Kamitani A, Rakugi H, Higaki J et al. Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis with angiotensinogen and angiotesnin converting enzyme. Hypertension 1995; 25: 950-3.
44. Ishigami T, Umemura S, Iwamoto T et al. Molecular variant of angiotensinogen gene is associated with coronary atherosclerosis. Circulation 1995; 91: 951-4.
45. Tiret L, Ricard S, Poirer O et al. Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction: The ECTIM study. J. Hypertens. 1995; 13, 311-17.
46. Chowdhury TA, Dronsfield MJ, Jones AF, Bain SC. Angiotensin II receptor gene polymorphisms and risk of myocardial infarction. Lancet 1994; 344: 1502-3.
47. Lindpaintner K, Pfeffer MA, Kreutz R et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N. Engl. J. Med. 1995; 332: 706-11.
48. Celermajer DS, Sorensen KE, Barley J, Jeffrey S, Carter N, Deanfield J. Angiotensin-converting enzyme genotype is not associated with endothelial dysfunction in subjects without other coronary risk factors. Atherosclerosis 1994; 111: 121-6.
49. Proudler AJ, Crook D, Godsland IF, Collins P, Rosano GMC, Stevenson JC. Serum angiotesnin-I-converting enzyme activity in women with cardiological syndrome X: Relation to blood pressure and lipid and carbohydrate metabolic risk markers for coronary heart disease. J. Clin. Endocrinol. Metab. 1995; 80: 696-9.
50. Ludbrook J. On making multiple comparisons in clinical and experimental pharmacology and physiology. Clin. Exp. Pharmacol. Physiol. 1991; 18: 379-92.
51. Zee RYL, Bennett CL, Schrader AP, Morris BJ. Frequencies of variants of candidate genes in different age groups of hypertensives. Clin. Exp. Pharmacol. Physiol. 1994; 21: 925-30.
52. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N. Engl. J. Med. 1992; 326: 310-18.
53. Gohlke P, Linz W, Schøolkens BA et al. Angiotensin-converting enzyme inhibition improves cardiac function: role of bradykinin. Hypertension 1994; 23: 411-18.
54. Naftilan AJ, Pratt RE, Dzau VJ. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J. Clin. Invest. 1989; 83: 1419-24.
55. Rakugi H, Wang DS, Dzau VJ, Pratt RE. Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointimal formation. Circulation 1994; 90: 449-55.
56. Samani NJ, Martin DS, Brack M et al. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty. Lancet 1995; 345: 1013-16.
57. Faxon DP. Effect of high dose angiotensin-converting enzyme inhibition on restenosis: Final results of the MARCATOR study, a multicenter, double-blind, placebo-controlled trial of cilazapril. J. Am. Coll. Cardiol. 1995; 25: 362-9.
58. Holz J, Goetz RM. Vascular renin-angiotensin system, endothelial function and atherosclerosis. Basic Res. Cardiol. 1994; 89: 71-86.
59. Ruiz J, Blanché H, Cohen N et al. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc. Natl Acad. Sci. USA 1994; 91: 3662-5.
60. Ludwig E, Cornell PS, Anderson JL, Marshall HW, Lalouel J-M, Ward RH. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 1995; 91: 2120-4.
61. Schunkert H, Hense H-W, Holmer SR et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N. Engl. J. Med. 1994; 330: 1634-8.
62. Crabos M, Roth M, Hahn AWA, Erne P. Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts. Coupling to signaling systems and gene expression. J. Clin. Invest. 1994; 93: 2372-8.
63. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994; 90: 2622-8.
64. Iwai N, Shimoike H, Ohmichi N, Kinoshita M. Angiotensinogen gene and blood pressure in the Japanese population. Hypertension 1995; 25: 688-93.
65. Prasad N, O'Kane KPJ, Johnstone HA et al. The relationship between blood pressure and left ventricular mass in essential hypertension is observed only in the presence of the angiotensin-converting enzyme gene deletion allele. Q. Med. J. 1994; 87: 659-62.
66. Studer R, Reinecke H, Muller B, Holz J, Just H, Drexler H. Increased angiotensin-I converting enzyme gene expression in the failing human heart: Quantification by competitive RNA polymerase chain reaction. J. Clin. Invest. 1994; 94: 301-10.
67. Raynolds MV, Bristor MR, Bush EW et al. Angiotensin-converting enzyme DD genotype in patients with iscaemic or idiopathic dilated cardiomyopathy. Lancet 1993; 342: 1073-5.
68. Woodrow JC. Circulating ACE concentrations and progression to heart disease. Lancet 1994; 343: 353.
69. Raynolds MV, Perryman MB, Bristow MR. Circulating ACE concentrations and progression of heart disease. Authors' reply. Lancet 1994; 343: 353-4.
70. Fogarty DG, Maxwell AP, Doherty CC, Hughes AE, Nevin NC. ACE gene typing. Lancet 1994; 343: 851.
71. Marian AJ, Yu QT, Workman R, Greve G, Roberts R. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993; 342: 1085-6.
72. Marre M, Bernadet P, Gallois F et al. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 1994; 43: 384-8.
73. Nomura H, Koni I, Michishita Y, Morise T, Takeda R. Angiotensin-converting enzyme gene polymorphism in haemodialysis patients. Lancet 1994; 343: 482-3.
74. Zingone A, Dominijanni A, Mele E et al. Deletion polymorphism in the gene for angiotensin converting enzyme is associated with elevated fasting blood glucose levels. Hum. Genet. 1994; 94: 207-9.
75. van Dyk DJ, Erman A, Erman T, Chen-Gal B, Sulkes J, Boner G. Increased serum angiotensin converting enzyme activity in type T insulin-dependent diabetes mellitus: its relation to metabolic control and diabetic complications. Eur. J. Clin. Invest. 1994; 24: 463-7.
76. Schmidt S, Schone N, Ritz E et al. Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int. 1995; 47: 1176-81.
77. Schächter F, Faure-Delanef L, Guénot F et al. Genetic associations with human longevity at the APOE and ACE Loci. Nature Genetics 1994; 6: 29-32.
78. Pfeffer MA, Braunwald E, Moye LA et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N. Engl. J. Med. 1992; 327: 669-77.
79. Yusuf S, Pepine CJ, Garces C et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 1992; 340: 1173-8.
80. Cohn JN, Johnson G, Ziesche S et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N. Engl. J. Med. 1991; 325: 303-10.
81. Fischer SG, Lerman LS. DNA fragments differing by single base pair substitution are separated in denaturing gradient gel: Correspondence with the melting theory. Proc. Natl Acad. Sci. USA 1983; 80, 1579-83.